Scientific Advisory

Dr. Shinn-Zong Lin, Neurological consultation

Dr. Lin is the director of the Hualien Tzu Chi Hospital of Buddhist Tzu Chi Medical Foundation in Taiwan. He was the first person and pioneer to initiate the successful transplantation of fetal dopamine-rich mesencephalic tissue or stem cells into patients with Parkinson's disease in Taiwan. For his efforts and contributions in the field of stem cell therapies, he won the 2010 Outstanding Award of the American Academy of Neurotherapy and Regeneration. His expertise is the use of stem cells, brain stimulators, novel chemical drugs and brain tissue transplants to treat Parkinson's disease, epilepsy, dystonia, chorea, stroke, brain tumors and neurological diseases.

Dr. Shin-Yuan Chen, Parkinson's disease consultation

Dr. Chen is the director of the Department of Neurology at Hualien Tzu Chi Hospital. He is also the convener of the Parkinson's and Dyskinesia Treatment and Research Center. His expertise is in functional brain stereotactic surgery, Parkinson's disease and dyskinesia.

Dr. Te-Fu Chen, Anti-aging medicine consultation

Dr. Chen is the director of the Taiwan Anti-Aging Medical Research Center. He uses stem cells to treat aging-related diseases, such as neurodegenerative diseases, metabolic syndrome, etc. His expertise is in applied research on stem cells and growth factors and in field of anti-aging medicine, aesthetic medicine, obesity medicine, and neurosurgery.

Dr. Wen-Ming Sung, Aesthetic medicine consultation

Dr. Sung is the former director of Bu Lao Mansion of the Madenform Group, a director of the Taiwan Association of Hospital Medicine, and a guest lecturer at the Chung Hwa University of Medical Technology. His expertise is in the field of naturopathic medicine, aesthetic medicine, and anti-aging medicine that uses stem cell therapy.

Professor Yau-Huei Wei, Mitochondrial Research and Disease Scientific consultation

Prof. Wei is currently the Director of the Center for Mitochondrial Medicine and Free Radical Research, Changhua Christian Hospital, Changhua City, Taiwan. He was the permanent delegate to the General Assembly of IUBMB from The Taiwan Society for Biochemistry and Molecular Biology. He and several founding members established Asian Society for Mitochondrial Research and Medicine, and served as the Vice-President (2002-2005) and President (2005-2008) of the Society. He has been the President of Taiwan Society for Mitochondrial Research and Medicine (2007-2011). Dr. Wei's research has focused on “molecular and cellular biological studies of mitochondrial diseases, aging-related diseases and cancer” and “crosstalk between mitochondria and nucleus and metabolic shift in the differentiation of stem cells”. He was one of the first scientists to show that mitochondrial function decline and mitochondrial DNA (mtDNA) mutations are important contributory factors of human aging. He has been actively participated in the promotion of local and international collaborations in biomedical research and mitochondrial medicine.

Dr. Xian-Liang Zhou, Cardiovascular consultation

Dr. Zhou is the director of Outpatient Department of Fuwai Cardiovascular Hospital, Chinese Academy of Medical Sciences. Dr. Zhou has a relatively comprehensive grasp of the basic theories and professional knowledge of cardiology diseases. Many years of clinical practice have enabled him to master the diagnosis and treatment of common diseases and critically ill patients in the cardiology department. He has mastered modern skills in scientific research. He focuses on molecular biology techniques and using this technology in the diagnosis and treatment of cardiovascular diseases.

Dr. Jia-Fu Ji, Anti-cancer consultation

Dr. Ji is the dean of Peking University School of Clinical Oncology, Dean of Beijing Cancer Hospital, and Dean of Beijing Cancer Institute. Dr. Ji has been engaged in gastric cancer surgery clinical and scientific research for 36 years. He is the founder and promoter of China cancer standard surgery and perioperative treatment norms, and the first Chinese expert to serve as the chairman of the International Society of Gastric Cancer. He is currently the dean of Peking University Cancer Hospital and Peking University School of Clinical Oncology, the director of Beijing Institute of Cancer Prevention and Treatment, the director of the Key Laboratory of Malignant Tumor Pathogenesis and Translation of the Ministry of Education, and the director of Peking University Cancer Research Center.